Agenus
AGEN
#8421
Rank
S$0.37 B
Marketcap
S$8.26
Share price
3.06%
Change (1 day)
50.04%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): S$0.19 Billion

According to Agenus 's latest financial reports the company's current earnings are S$0.13 Billion. In 2025 the company made an earning of S$67.33 Million, an increase over its 2024 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.19 B188.97%
2025 S$67.33 M-145.52%
2024 -S$0.15 Billion-28.13%
2023 -S$0.21 Billion-5.5%
2022 -S$0.22 Billion-556.26%
2021 S$47.73 M-130.37%
2020 -S$0.16 Billion73.75%
2019 -S$90.46 Million-48.74%
2018 -S$0.18 Billion34.32%
2017 -S$0.14 Billion-7.16%
2016 -S$0.15 Billion26.55%
2015 -S$0.12 Billion110.24%
2014 -S$53.19 Million49.12%
2013 -S$35.67 Million
2011 -S$24.63 Million-12.25%
2010 -S$28.07 Million-21.41%
2009 -S$35.72 Million-26.86%
2008 -S$48.83 Million13.72%
2007 -S$42.94 Million-33.4%
2006 -S$64.47 Million-31.84%
2005 -S$94.59 Million9.74%
2004 -S$86.19 Million-0.8%
2003 -S$86.89 Million17.37%
2002 -S$74.03 Million37.83%
2001 -S$53.71 Million55.99%
2000 -S$34.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B 12,294.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B 4,351.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.62 B 7,402.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.23 B 4,636.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.43 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA